Abstract:AIM:To investigate the synergistic effect of toosendanin on regulating the cytotoxicity of γδ T cells to colorectal cancer cells. METHODS:γδ T cells amplified in vitro were identified by flow cytometry. Lactate dehydro-genase (LDH) release was detected to evaluate the cytotoxicity of γδ T cells and toosendanin to SW480 cells. The role of toosendanin in regulating the protein expression of Bcl-xL,Bcl-2 and MCL-1 was determined by Western blot. The effect of toosendanin on regulating the secretion of TNF-related apoptosis-inducing ligand(TRAIL) and Fas ligand(FasL) by γδ T cells was evaluated by ELISA. The mitochondrial membrane potential and apoptosis in SW480 cells treated with γδ T cells and toosendanin were analyzed by flow cytometry. The activation of caspase-9 and caspase-3 were determined by Western blot. RESULTS:CD3 and γδ T-cell receptor(TCR) were highly expressed in the γδ T cells amplified in vitro. Combina-tion with toosendanin significantly enhanced the cytotoxicity of γδ T cells to SW480 cells. Toosendanin did not influence the secretion of TRAIL and FasL secreted by γδ T cells. Toosendanin did not regulate the expression of Bcl-xL and Bcl-2 but suppressed the expression of MCL-1 in SW480 cells. In addition, enforced expression of MCL-1 obviously suppressed the synergistic effect of toosendanin on γδ T cell-induced cell death in SW480 cells. Meanwhile,co-treatment with toosendanin was able to enhance the γδ T cell-induced apoptosis and decrease of mitochondrial membrane potential. γδ T cell-depend-ent activation of caspase-9 and caspase-3 was significantly enhanced by toosendanin co-treatment in SW480 cells. CON-CLUSION:Toosendanin exerts synergistic effect on γδ T cell-induced cytotoxicity to colorectal cancer by suppressing the expression of MCL-1.

The Apoptotic Effects Of Toosendanin Are Partially Mediated By Activation Of Deoxycytidine Kinase In Hl-60 Cells

Toosendanin induces apoptosis through suppression of JNK signaling pathway in HL-60 cells.

Involvement of Cytochrome C Release and Caspase Activation in Toosendanin-Induced PC12 Cell Apoptosis

Effect of Toosendanin on the Apoptosis of Human Ovarian Cancer Cells Through Mitochondrial Pathway

Toosendanin-induced Apoptosis in Colorectal Cancer Cells is Associated with the Κ-Opioid Receptor/β-Catenin Signaling Axis.

Reversal of the Apoptotic Resistance of Non-Small-Cell Lung Carcinoma Towards TRAIL by Natural Product Toosendanin

Mechanisms involved in the anti-tumor effects of Toosendanin in glioma cells

Anti-cancer Effect of Toosendanin and Its Underlying Mechanisms

Toosendanin Induces Caspase-Dependent Apoptosis Through the P38 MAPK Pathway in Human Gastric Cancer Cells.

Mechanism of Apoptotic Induction on T24 Cells by Honokiol and Its Synergistic Anticancer Effect in Combination with Hydroxycamptothecin

Toosendanin Induces Lung Squamous Cell Carcinoma Cell Apoptosis and Inhibits Tumor Progression Via the BNIP3/AMPK Signaling Pathway

Toosendanin: upgrade of an old agent in cancer treatment

Toosendanin Induces the Apoptosis of Human Ewing's Sarcoma Cells Via the Mitochondrial Apoptotic Pathway

Toosendanin Induces Outgrowth of Neuronal Processes and Apoptosis in PC12 Cells

Biological effects of toosendanin, a triterpenoid extracted from Chinese traditional medicine.

Toosendanin and isotoosendanin suppress triple-negative breast cancer growth via inducing necrosis, apoptosis and autophagy

Toosendanin exerts synergistic effect on γδ T cell-induced cytotoxicity to colorectal cancer by suppressing expression of MCL-1

Low concentrations of trichosanthin induce apoptosis and cell cycle arrest via c-Jun N-terminal protein kinase/mitogen-activated protein kinase activation.

Inhibition of Toosendanin on the Delayed Rectifier Potassium Current in Neuroblastoma×glioma NG108-15 Cells

Toosendanin Induces Hepatocyte Damage by Inhibiting Autophagic Flux Via TFEB-Mediated Lysosomal Dysfunction

Design, synthesis, and anti-triple negative breast cancer activity of novel Toosendanin derivatives